CanSino Biologics, Inc. Class A 688185

As global markets react to geopolitical developments and economic data, Asian equities present a unique landscape of opportunities and challenges. In this environment, identifying undervalued stocks requires a keen understanding of market sentiment and macroeconomic factors that could influence future growth potential.

CanSino Biologics Inc. ("CanSinoBIO"; SSE: 688185, HKEX: 06185) has been invited to share the practices of innovative vaccine at the World Government Summit 2026 (WGS 2026) which convened from February 3 to 5 in Dubai, UAE under the theme of "Shaping Future Governments." CanSinoBIO stands the sole global vaccine maker invited to the World Government Summit for the second consecutive year.

As global markets navigate a complex landscape marked by economic uncertainties and policy shifts, Asian markets have shown resilience, with notable activity in sectors like technology and consumer goods. In this context, companies that combine strong earnings growth with high insider ownership can offer potential stability and alignment of interests between management and shareholders.